You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
先聲藥業(02096.HK):仲裁勝訴
格隆匯 02-25 06:15

格隆匯2月25日丨先聲藥業(02096.HK)發佈公吿,2022年2月22日,公司的附屬公司先聲藥業有限公司(“先聲藥業”)接獲上海國際經濟貿易仲裁委員會(上海國際仲裁中心)(“上仲委員會”)的一項仲裁裁決。就先聲藥業2017年7月與子博有限公司、東菱藥品工業株式會社、千賀博文(合稱“被申請人”)簽署的有關轉讓北京託畢西藥業有限公司100%股權的《股權轉讓協議》及《合作協議》爭議,上仲委員會裁定(其中包括)如下:(i)子博有限公司繼續履行,將其對目標公司的100%股權轉讓予先聲藥業;(ii)東菱藥品工業株式會社、千賀博文對所涉《股權轉讓協議》的繼續履行義務承擔連帶責任。該裁決為終局裁決,自作出之日起生效。

2020年3月27日,因被申請人違約,上仲委員會曾就該等協議做出裁定(“前案”),要求被申請人按照該等協議連帶支付人民幣5000萬元的特別違約金。前案仲裁裁決被申請人尚未履行。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account